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Comparison of Intravascular Ultrasound With
Coronary Angiogrsphy
G.S.Mintz, K.M. Kent, A.D. Pichard, L.F.Satler, J.J. Popma, J. MacKenzie,
C. EweIs, K. Morgan, J. DeVries, M.B. Leon. WashingtonHospital Cerrtec
Washington, DC, USA
Lesions in small native coronaty arteries are thought to contain more target
lesion calcium (Ca). To test this, we studied 1111de novo, non-ostial native
veaael lesions. Coronary angiography was used to measure referencevessel
size, minimum lumen diameter, and diameter stenosis (DS) and to assess
target lesion Casemi-quantitatively. Pre-intervention intravascularultrasound
(IVUS) was used to measure arcs of target lesion Ca and superficial Ca.
Refereneevesselize(mm)
<2.o N =51 2.1-2,5 N = 231 >2.5 N = 829 D
Anglogrephy
DS 65& 22 64*2O 63k 21 0.6217
None/mild(%) 50.9 54.5 60.8
Moderate(%) 29.4 32.5 26.8 0.1132
Sevsre(%) 19.6 13.0 12.4 I
Ivus
ArcofCa 185k 124 115* 110 108 + 109 0.0030
ArcofCa>1809 (%) 42.2 26,8 23.1 0,0118
Arcof superficialCa 154 + 125 113 * 111 104 * 109 00090
cured by angiogrsphic minimum lumen diameter or diameter stenosis) and
IVUS Ieeion Ca. We conclude: Pre-intetvention IVUS shows that target le-
sione in emall veesele do indeed contain more calcium and supeti”cial cal-
dum. However, this increased cslcifiestion in small vessels is not observed
during conventional angiography.
1906-421Safety oflntrevaS~u,ar U~raaound,nCardia~
Transplant Recipients
E.L. Mayer, A.C. De France, R.E. Hobbs, V.Guetta, M. Goormastic,
J.B. Young, E.M. Tuzcu. The Cleveland Clinic Foundation, C/eva/and, OH,
USA
Background: Intravascular ultrasound (IVUS) is a sensitive method for as-
aeaamantof allograft vsaculopathy in cardiac transplant recipients, however,
concema have been raised regarding the aafety of routine coronary instru-
mentation.
Methods: To evaluate the safety of IVUS in transplant recipients, we
analyzed 1) immediate complications, 2) long-term advereeclinical events by
comparing clinical outcomes during a pre-lVUS year (2/91-9/92) to a period
in which IVUS was routinely used (2/93-9/94), 3) evidence of acceleration
of atherosclerosis due to arterial instrumentation (by comparing disease in
instrumented vs non-inetrumented vessels).
Resu/ts: Between 293 and 4/96, we imaged 667 arteriee during 408
examinations in 281 patients. 1) there were no diesectione,thrombi, myocar-
dial infarctions, emergency bypass surgery,death, OrvascuIarComPli~tions
requiring transfusion or surgical repair. Coronary spasm occurred in 4%,
reeolving promptly with nitroglycerin, 2) Comparing 176 patients from the
pre-lVUS ereto286 patients in the IVUS era, there was no difference in mor-
tsfity (6.0% vs 6.6%, p = 0.26) or incidence of myocardial infarction (1.90/.
vs 2.2’7., p = 0.45), 3) A total of 29 arteriee (13 IAD, 10 Lcx, 6 RCA) were
imaged in 19 patients within 4 weeke of transplantation, and again at 1 year.
An additional 21 arteries (4 LAD, 7 Lcx, 10 RCA) not previously imaged, and
those imaged for the first time, demonstrated no difference in maximal (0.74
+ 0.4S mm vs 0.61 + 0.5 mm, p = 0.23) or mean plaque thickness (0.43 +
0.26 mm VSO.38+ 0.33 mm, p = O.18).
Conclusion: Routine use of intravascular ultrasound in transplant recipi-
enceis not associated with eerious immediate complications, increased mor-
tality, myocardial infarction or acceleration of atherosclerosis in the imaged
sagmenta.
1906-431 lntmvaeCUlaruhraaOUndTiSaUeCharaCteriZatiOn
Predicte Local Vasoreactivity in Early Coronary
Atherosclerosis
A. Manginas, V. Voudris, G. Pavlides, G. Karatasakis, G. Athanassopoulos,
V. Vaasilikos, D.V. Cokkinos. Onassis Cardiac Surgery Centec Atfrans,
Greece
Intravascular ultrasound (IVUS) isemployedforevaf uation of the morphology
of earty coronaiy atherosclerotic plaques. We studied 32 corona~ segments
with non-significant diameter stenosis, using quantitative angiography and
IVUS. Local vasoreactivity wasangiographically assessedafter intracoronary
infusioneof acetylcho!ine (Ach) 10-8 M and 10-5 M and Nitroglycerine (NTG)
0,2 mg. Following NTG, IVUS was used to evaluate the morphology and
composition of the corona~ plaques. The following IVUS parameters were
obtained: maximal (MT) and minimal (mT) plaque + media thickness, veeael
area (VA), lumen area (LA), plaque area (PA), minimal lumen diameter
(MLD) and eccentricity index (El). Planimetry of the fibrous elements within
the plaque was used to categorize them as soft, mixed and fibrous, according
to standard criteria.
MT was 1.09 + 0.3 mm and mT 0.43 + 0.2 mm. By IVUS, 12 plaques
were soft, 16 mixed and 4 fibrous. During Ach, mean % diameter reduction
was 6.9 + 12,6% for Arch 10-6 M and 18.8 + 25.5% for Ach 10-5 M. The
degree of vasoconatriction to Ach correlated inversely to the MT (p = 0.001),
the mT (p = 0.004) and PA (p =0.004), Compared to eoft plaques, atheroscle-
rotic segments with mixed composition by IVUS exhibited significantly more
vasoconstricfion to Ach (p= 0.008) and vasodilation to NTG (p= 0.01).
Cone/usiorr:In premature atherosclerotic plaques a) Ach induced vaso-
constricfion correlates inversely to the amount and thickness of the plaque-
media as detected by IVUS and b) coronary plaques with mixed echogenic
elements exhibit significantly greater vasoreactive responeestoendothelium-
dependent and independent stimuli compared to plaques with homogeneous
IVUS composition.
[906-44]Evaluation of Coronary Vesse,Wa,l Compliance by
Intravascular Ultrasound: Importance of Plaque
Distribution in Determining Regional Distensibility
M. Yamagishi, H. Tsutsui, T. Umeno, S. Nakatani, Y. Goto, K. Miyatake.
National Cardiovascular Centar, Suita Osaka, Japan
The previous studies ehowed that a coronaty attery compliance is impaired
in the presence of atherosclerosis. However, few data exist regarding the
regional vessel wall distensibility. Therefora, the regional distensibility was
determined by measuring Iuminal area and pressure using intravascular ul-
trasound (3.5 Fr, 30 MHz) in 45 left mrona~ sites from 40 patients. Luminal
area in diastole (A) and in systole was measured at the diseased aitea. With
the retioof Iuminalareachanges (dA)tocoronary pressure changes (dP)dur-
ing a cardiac cycle, the total distensibility index was calculated bytheformula:
{(dArA)/dP} x l@. At the sites with non-circumferential disease, perimeters
in diastole (L) and in systole were measured at the normal and dieeased
pationa, and the changes in perimeters (dL) during a cardiac cycle were
calculated. The regional distensibility index was obtained by the formula:
{(dUL)/dP} x l@. In 22 sites with circumferential dieease, the total disten-
sibility index was 1.03 + 0.61/mmHg, and significantly lower than that from
23 sites with non-circumferential diseaae that showed 1.45 + 0.89/mmHg (p
< 0.05). In non-circumferential disease, the regional distensibility index at
diseased portion waa significantly lower, 0.33+ 0.47/mmHg, than that at nor-
mal portion, 1.11 Z+0,75/mmHg (p < 0.01). The coronary cites with residual
non-circumferential disease after angioplasty also exhibited the heterogene-
ity of regional distensibility (0.73 + 0.76 in disease vs 1.56 + 0.95/mmHg
in normal, n = 10, p < 0.05). Theae results indicate that the heterogeneous
regional wall distensibility exists at the sites with non-circumferential disease
where the total vesael distensibility is preserved by the presence of the com-
pliant normal portion. This heterogeneity of the regional wall distensibility can
be a biomechanical factor explaining the mechanism of plaque rupture that
mainly occurs at the shoulder of the non-circumferential diseaae.
1906-601GenderandHormonalEflectsonPlaque
Composition and Burden as Assaased by
Intracoronary Ultrasound and 3-Dimensional
Reconstruction
T. Caulin-Glaser, J.F. Setaro, K. Bunger, M, Remetz, W. Farrell, S. Pfau,
J. Brennan, H. Cabin, M. Cleman.. Ya/eSchoo/offdedicina, New Haven, CT
USA
The incidence of cardiovascular disease ia lower in women compared to
men but increases after menopause. Estrogen (Ez) exerts an inhibitory effect
on the development of CAD in women. The antiatherosclerotic effects of
EZ on lipid profile account for 30-50% of this benefit. Inhibition of plaque
development can occur in response to EZ in the absence of alterations in
lipid levels. In this study we evaluate risk factors, lipid profile and E2 levels of
40 patienta referredforcetheterization procedures. Pre-intervention coronary
intravascular ultrasound (IVUS) with 3-D reconstruction was performed and
read in a blinded fashion to aasess plaque composition, % stenosis, and
plaque burden.
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Cone/usions:The plaque comrmsition issimilarinmenand postmenopausal
women (-)E2 who have CAD. Plaque burden is less in postmenopausal
women (+) E2 and premenopeusal women (+) CAD wmpared to men and
postmenopausal women (–)E2. In postmenopausal women (+) E2, the %
stenosie is lees than postmenopausal women (-)E2. Estrogen is associated
with a decrease in Y. stenoeie and may favorably alter plaque composition in
postmenopausal women.
\906-61)Redu~~ionin~~~g~~~*i~n~f~ ~~ *V
T. Takegi, K. Yoshida, T. Akasaka, T. Hozumi, S. Morioka, J. Yoshikawa.
Kobe General Hospital, Kobe, Japan
To determine whather pravastatin reduces the progression of coronary
atherosclerotic plaque, 25 patients with elevated LDLchoresterol level 23.36
mmof/1were studied. The study patients were randomized into two groups:
prevastatin group, 13 patients w o
stabilization, and control group, 12 patients treated with diet stabilization
only. All patients underwent intravascular ultrasound (IVUS) studies before
and after the 3 yaare treatment period. IVUS images wera obtained in an-
giographicelly normal Coronary artery (% stenosis .c25%) ueing 4.3 F, XI
MHz IVUS catheter (CVIS) with motorized pullback (1.0 mrnkec). A cross
sectional image waa selected evey 1 see, and external elastic membrane
aree (EEM), lumen area (U), plaque area (PA= EEM – LA) ware measured
ueing computer planimetry and averaged over 10 framee. Results: There
wae no significant difference in LDL cholesterol level at baseline between
two groupe (4.6 + 0.5 mmolll in pravastatin group and 4.2 + 0.5 mmolil in
control group). LDLcholesterol reduction during treatment period waegreater
in prevastetin group than that in control group (26% vs 9%, respectively, p
< 0.005). There was no significant difference in plaque erea at baseline
betwean two groups (8.0 &2.7 mmz in pravastatin group and 7.3+ 1.9 mmz
in control group). Progression of the plaque area during treatment period
wae smaller in group than that in control group (-6% vs 41Y0,
respectively, p < 0.0005). Conclusion: Administration of pravastatin reduces
the progression of corona~ atherosclerotic plaque.
AeeasernentoflnterfnSdiateCorOnaWS@nosis~Y
RelativeCoronaryFlowVelocityReserve
M.J. Kern, T.J. Donohue, R.G. Bach, F.V.Aguirre, E.A. Careeciolo,
T.L. Wolford. Saint Louis University Health Sciences Center, St. Louis, MO,
USA
Post-stenotic coronafyflow resewe (CFR) represents the summed responee
of the conduit and microvaacularcirculation. CFR alone is not Ieeion-specific.
To aseeea intermediate left anterior descending and circumflex coronary
artery etenoaes with a Iesion-epecific meaauremant, intracoronary flow ve-
Ioeity resewe (CFR = adenosine hyperemiaheal mean flow velocity) was
measured with a 0.014 in. Flowire in a target (normal or etenotic) vessel
and an adjacent angiographieelly normal reference vessel. Relative CFR
wee computed aa CFR targetiCFR reference in 46 petienta with l-vessel
corona~ artery dieease and in 30 patients with normal left coronaty arteries.
Reaulta (mean+ SD).
CFR
+ +
+ +
lp <0.001 $ p
Relative CFR was related to percent diameter stenosie (r = 0.44; p =
0.0012). Concordance of CFR =. 2.0 in patients with normal vessels was
56/80 (90%). In patiants with l-vessel coronary artery disease, concordance
of CFR >2.0 was 23/’79 (29%).
These findings suggest that in patients with intermediate lesions, the
precision of post-stenotic CFR for lesion-specific flow impairment can be
improved using relativeCFR which utilizes an adjacent normal reference
vessel.
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J. Koyama, M. Owa, K. Asakawa, H. Hikita, K. Ohkubo, M. Shindo,
N. Yanagisawa. Shinshu University Matsumoto, Nagano, Japan
A variable degree of smooth muscle cell proliferation after balloon inju~ haa
been reported in enimal models. Although balloon angloplasty often dilates
non-stenotic coronary segments (NS) next to stenotic lesions in the clinical
settings, little is known about the influence of balloon dilation in NS. To clarity
the exietence of intimal proliferation in NS, intravascular ultrasound (IVUS)
was performed before and after balloon angioplasty and at remote phase
(after 3-S months) in 39 mrona~ segments from 22 patients. The lumen
area (LA), total vascular araa within the axfemal elastic Iamina (TA), and
plaque area (PA = TA – LA) were measured at NS and reference sites that
are not influenced by balloon dilation.
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Balloon dilation increaeed TA and PA significantly but did not change
LA. TA, LA and PA at reference sites were unchanged (p = N.S.). When
the degree of intimal proliferation was plotted against the distensibility of
coronary arteries ((post LA-pra LA)/pre IA), there was significant inverse
correlation (y = –0.678 x +33, r = 0.62, P < 0.05). Theee data suggest that
intimal proliferation occurs after balloon dilation in angiographically normal
segments and its response is proportional to the degree of balloon injury. If
vaecular distensibility is poor, the vessel wall will be damaged more severely.
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K, Jansson 1, K.-E. Karlberg2, E. Nylander’, E. Karlsson O. Nyqvist2,
U. Dahlstr6m. Linkdping Heart Centac Huddinge University Hospital,
Sweden, 2Linkc3pingUniversity Hespitaland Dept of Cardiology, Huddinge
University Hospital, Swedan
Objective.’Tostudy the effects of treatment with beta raceptor blockar (meto-
prolol) or an angiotensin-convetiing-enzyme inhibitor (captopril) on left ven-
tricular (LV)function in 53 patients with idiopathic dilated cardiomyopathy.
Method Cardiac cathetarisation was performed at rest and during supine
exercise before and after 3 months of treatment.
Resu/ts:Themean dose of metoprolol wae 135 mg perdayand of eapfopril
96 mg per day. Regarding left ventricular filiing pressure (PCW) and cardiac
output there was no differences between tha two groups at baseline. After
treatment there was a significant reduction in PCW both at rest (from 16 to
12 mm Hg) and during exercise (from 27 to 20 mm Hg) in the metoproiol
group. In the captopril treated patients there was no difference at rest but a
eignificent reduction was seen during exercise (25 to 20 mm Hg) compared
to baeeline. LVstroke volume (SV) was iowerat baseline in the group treated
with metoprolol than in the group traated with captopril (53versua 62 ml). The
SV increased significantly after 3 months of therapy in the metoprolol group,
both et rest (53 to 70 ml) and during exarcise (56 to 79 ml). In the ceptopril
group the increase reached significance only during exercise (72 to 79 ml).
Cardiac out-put was maintained in both groups. When comparing the change
from baseline, therapy with metoprolol reduced PCW at rest and increased
SV both at rest and during exercise significantly more than captopril did.
/n conclusion: Both treatments had positive effecte on LV function in
patients with dilated cardiomyopathy, but the effects of metoprolol were
greater,
